Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Reed Larsen

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
The Journal of Clinical Investigation|May 5, 2011
IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cellsSimone Magagnin Wajner, Iuri Martin Goemann, Ana Laura Bueno, et al.
Endocrinology|December 8, 2009
Substitution of serine for proline in the active center of type 2 iodothyronine deiodinase substantially alters its in vitro biochemical properties with dithiothreitol but not its function in intact cellsIuri Martin Goemann, Balázs Gereben, John W Harney, et al.
Hypertension (Dallas, Tex. : 1979)|February 21, 2008
Lack of association between the type 2 deiodinase A/G polymorphism and hypertensive traits: the Framingham Heart StudyAna Luiza Maia, Shih-Jen Hwang, Daniel Levy, et al.
Endocrinology|March 8, 2014
Inflammation-inducible type 2 deiodinase expression in the leptomeninges, choroid plexus, and at brain blood vessels in male rodentsGábor Wittmann, John W Harney, Praful S Singru, et al.
Metabolites|July 27, 2022
Modulation of Deiodinase Types 2 and 3 during Skeletal Muscle RegenerationAshley Ogawa-Wong, Colleen Carmody, Katherine Le, et al.
Endocrine Connections|October 16, 2014
Long-term, treatment-free survival in select patients with distant metastatic papillary thyroid cancerNorra Kwong, Ellen Marqusee, Michael S Gordon, et al.
The Journal of Clinical Endocrinology and Metabolism|August 23, 2014
N-acetylcysteine administration prevents nonthyroidal illness syndrome in patients with acute myocardial infarction: a randomized clinical trialJosi Vidart, Simone Magagnin Wajner, Rogério Sarmento Leite, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 21, 2011
Type II iodothyronine deiodinase provides intracellular 3,5,3'-triiodothyronine to normal and regenerating mouse skeletal muscleAlessandro Marsili, Dan Tang, John W Harney, et al.
Molecular Endocrinology (Baltimore, Md.)|August 23, 2003
Endoplasmic reticulum-associated degradation of the human type 2 iodothyronine deiodinase (D2) is mediated via an association between mammalian UBC7 and the carboxyl region of D2Brian W Kim, Ann M Zavacki, Cyntia Curcio-Morelli, et al.
Endocrinology|February 16, 2017
Characterization of the 5'-Flanking and 5'-Untranslated Regions of the Cyclic Adenosine 3',5'-Monophosphate-Responsive Human Type 2 Iodothyronine Deiodinase Gene1Tibor Bartha, Sung-Woo Kim, Domenico Salvatore, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Investigation|May 5, 2011
IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cellsSimone Magagnin Wajner, Iuri Martin Goemann, Ana Laura Bueno, et al.
Endocrinology|December 8, 2009
Substitution of serine for proline in the active center of type 2 iodothyronine deiodinase substantially alters its in vitro biochemical properties with dithiothreitol but not its function in intact cellsIuri Martin Goemann, Balázs Gereben, John W Harney, et al.
Hypertension (Dallas, Tex. : 1979)|February 21, 2008
Lack of association between the type 2 deiodinase A/G polymorphism and hypertensive traits: the Framingham Heart StudyAna Luiza Maia, Shih-Jen Hwang, Daniel Levy, et al.
Endocrinology|March 8, 2014
Inflammation-inducible type 2 deiodinase expression in the leptomeninges, choroid plexus, and at brain blood vessels in male rodentsGábor Wittmann, John W Harney, Praful S Singru, et al.
Metabolites|July 27, 2022
Modulation of Deiodinase Types 2 and 3 during Skeletal Muscle RegenerationAshley Ogawa-Wong, Colleen Carmody, Katherine Le, et al.
Endocrine Connections|October 16, 2014
Long-term, treatment-free survival in select patients with distant metastatic papillary thyroid cancerNorra Kwong, Ellen Marqusee, Michael S Gordon, et al.
The Journal of Clinical Endocrinology and Metabolism|August 23, 2014
N-acetylcysteine administration prevents nonthyroidal illness syndrome in patients with acute myocardial infarction: a randomized clinical trialJosi Vidart, Simone Magagnin Wajner, Rogério Sarmento Leite, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 21, 2011
Type II iodothyronine deiodinase provides intracellular 3,5,3'-triiodothyronine to normal and regenerating mouse skeletal muscleAlessandro Marsili, Dan Tang, John W Harney, et al.
Molecular Endocrinology (Baltimore, Md.)|August 23, 2003
Endoplasmic reticulum-associated degradation of the human type 2 iodothyronine deiodinase (D2) is mediated via an association between mammalian UBC7 and the carboxyl region of D2Brian W Kim, Ann M Zavacki, Cyntia Curcio-Morelli, et al.
Endocrinology|February 16, 2017
Characterization of the 5'-Flanking and 5'-Untranslated Regions of the Cyclic Adenosine 3',5'-Monophosphate-Responsive Human Type 2 Iodothyronine Deiodinase Gene1Tibor Bartha, Sung-Woo Kim, Domenico Salvatore, et al.
Pageof 10